In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 13.27 above Buda Juice Inc average.

Within Nonalcoholic Beverages industry Buda Juice Inc booked the highest Quick Ratio than Buda Juice Inc in the second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 156 to 307.

Explain Quick Ratio?
How much Cash & cash equivalents BUDA�s has?
What are BUDA�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BUDA Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Dec 31 2024) Q2	Q1
Y / Y Current Liabilities Change	-	-	-	-	-
Y / Y Cash & cash equivalent Change	-	-	-	-	-
Quick Ratio MRQ	13.27	19.05	3.15	4.2	-
BUDA's Total Ranking	# 307	# 156	# 0	#	#
Seq. Current Liabilities Change	36.22 %	77.95 %	30.29 %	-	-
Seq. Cash & cash equivalent Change	-5.09 %	977.61 %	-2.49 %	-	-

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Nonalcoholic Beverages Industry	# 1
Consumer Non Cyclical Sector	# 5
Overall Market	# 307

Quick Ratio Statistics
High	Average	Low
19.05	9.92	3.15
(Mar 31 2026)		(Dec 31 2025)

Financial Statements
Buda Juice Inc 's Current Liabilities	$ 1 Millions	Visit BUDA's Balance sheet
Buda Juice Inc 's Cash & cash equivalent	$ 19 Millions	Visit BUDA's Balance sheet
Source of BUDA's Sales		Visit BUDA's Sales by Geography

Cumulative Buda Juice Inc 's Quick Ratio

BUDA's Quick Ratio for the trailling 12 Months

BUDA Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Dec 31 2024) 12 Months	12 Months
Y / Y Current Liabilities TTM Growth	-	-	-	-	-
Y / Y Cash & cash equivalent TTM Growth	-	-	-	-	-
Quick Ratio TTM	12.13	11.35	3.6	4.2	-
Total Ranking TTM	#	#	#	#
Seq. Current Liabilities TTM Growth	68.34 %	100.68 %	130.29 %	-	-
Seq. Cash & cash equivalent TTM Growth	79.89 %	532.01 %	97.51 %	-	-

Quick ratio ranking by company, industry and sector >> Back to BUDA Financial Strength Comparisons >> Go to Compare BUDA Quick Ratio to its Competitors

On the trailing twelve months basis BUDA Cash & cash equivalent decreased by -5.09 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Buda Juice Inc 's Quick Ratio to 12.13, above BUDA average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Nonalcoholic Beverages industry BUDA achieved the highest Quick Ratio. While overall ranking is unchanged compared to the previous 12 months at no. 0.

Explain Quick Ratio?
How much Cash & cash equivalents BUDA�s has?
What are BUDA�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Nonalcoholic Beverages Industry	# 1
Consumer Non Cyclical Sector	# 5
Within the Market	# 307

trailing twelve months Quick Ratio Statistics
High	Average	Low
19.05	9.92	3.15
(Mar 31 2026)		(Dec 31 2025)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Nonalcoholic Beverages Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Srx Health Solutions Inc	21.19	$ 50.188 Millions	$ 2.368 Millions
Buda Juice Inc	13.27	$ 18.819 Millions	$ 1.418 Millions

Date modified: 2026-09-08T16:57:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.